# Incyte (INCY) Forecast Calculator

Interactive five-year financial forecast and DCF for Incyte. Adjust revenue growth, margins, capex, and WACC to update revenue, free cash flow, and enterprise value.

- Canonical: https://finamodel.com/companies/incyte/forecast
- Industry: Healthcare
- Forecast start year: 2026

## Historical data

| Year | Revenue | Free cash flow | EBITDA | Net income |
|---:|---:|---:|---:|---:|
| 2021 | 2158759000 | 632592000 | 456539000 | 446906000 |
| 2022 | 2666702000 | -311978000 | -211869000 | -295697000 |
| 2023 | 2986267000 | 722390000 | 643621000 | 948581000 |
| 2024 | 3394635000 | 921241000 | 647295000 | 340660000 |
| 2025 | 3695649000 | 447787000 | 703185000 | 597599000 |

## Frequently asked questions

### What does Incyte Corporation do?

Incyte Corporation is a global commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of proprietary therapeutics. It primarily operates in the areas of haematology, oncology, and inflammation and autoimmunity.

### How does Incyte generate its revenue?

Incyte's revenue is primarily driven by Net Product Revenues, which constitute approximately 85% of its total revenue. The company also generates significant Royalty Revenues, accounting for about 13%, with Milestone and Contract Revenues making up the remaining 2%.

### What are the key financial assumptions in the Incyte model?

Key financial assumptions in the Incyte model include a revenue growth rate of approximately 14.4% and COGS as a percentage of revenue around 5.7%. Research and Development (R&D) is assumed to be 35% of revenue, while Selling, General, and Administrative (SGA) expenses are modeled at about 25.3% of revenue.

### How does Incyte's asset-light business model impact its capital expenditures?

Incyte operates an asset-light manufacturing model, outsourcing production to third-party organizations. This results in minimal capital expenditures, typically ranging from 1-3% of revenue, primarily for maintenance and minor lab expansions rather than growth-related investments.

### Where can I download a financial model for Incyte?

A comprehensive Excel financial model for Incyte is available for download, designed as an equity valuation and scenario planning tool. This model helps users assess the company's financial performance and strategic outlook.

### What is the primary purpose of the Incyte financial model?

The primary purpose of the Incyte financial model is to provide an equity valuation and scenario planning tool for analysts and portfolio managers. It helps assess Incyte's ability to offset the impending loss of exclusivity for Jakafi through the growth of Opzelura, recent launches, and its clinical pipeline.